NAD+ · 500mg · RESEARCH COMPOUND
RESEARCH COMPOUND
NAD+
Nicotinamide adenine dinucleotide, oxidised form.
Description
NAD+ is the oxidised form of nicotinamide adenine dinucleotide, a central redox cofactor in cellular metabolism and a substrate for the sirtuin and PARP enzyme families. Supplied as a lyophilised powder.
Specification
- Form
- Lyophilised powder
- Presentation
- Sealed single vial
- Storage
- 2–8 °C, protect from light
- Catalogue code
- NAD+-500MG
Research use only
This material is sold strictly as a laboratory reagent for in-vitro and preclinical research by qualified professionals. It is not a drug, food, cosmetic or medical device, and it is not for human or veterinary consumption. Noxera publishes no handling, preparation or administration guidance of any kind.
Related
Others in Metabolic & Cofactors
GLP-1 Compounds
Tirzepatide
5 sizes · 10mg–60mg
Dual GIP / GLP-1 receptor agonist, lyophilised.
GLP-1 Compounds
Retatrutide
5 sizes · 10mg–60mg
Triple GIP / GLP-1 / glucagon receptor agonist.
